A detailed history of Great Valley Advisor Group, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 6,698 shares of INCY stock, worth $455,865. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,698
Previous 5,631 18.95%
Holding current value
$455,865
Previous $320,000 26.88%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$51.18 - $63.75 $54,609 - $68,021
1,067 Added 18.95%
6,698 $406,000
Q1 2024

May 03, 2024

BUY
$56.55 - $66.59 $318,433 - $374,968
5,631 New
5,631 $320,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Great Valley Advisor Group, Inc. Portfolio

Follow Great Valley Advisor Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.